Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Incorrect Wording

Incorrect Wording In the From the Food and Drug Administration column published in the February 4, 1998, issue of THE JOURNAL (1998;279:346), there was incorrect wording under the heading "Two New Warnings Added to Labeling for Mibefradil." Mibrefadil is not contraindicated for patients concurrently receiving fluvastatin. The 2 drugs for which a new warning states that concurrent use with Mibefradil is contraindicated are lovastatin and simvastatin. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Incorrect Wording

JAMA , Volume 279 (12) – Mar 25, 1998

Incorrect Wording

Abstract

In the From the Food and Drug Administration column published in the February 4, 1998, issue of THE JOURNAL (1998;279:346), there was incorrect wording under the heading "Two New Warnings Added to Labeling for Mibefradil." Mibrefadil is not contraindicated for patients concurrently receiving fluvastatin. The 2 drugs for which a new warning states that concurrent use with Mibefradil is contraindicated are lovastatin and simvastatin.
Loading next page...
 
/lp/american-medical-association/incorrect-wording-nZN307URIf
Publisher
American Medical Association
Copyright
Copyright © 1998 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.279.12.913
Publisher site
See Article on Publisher Site

Abstract

In the From the Food and Drug Administration column published in the February 4, 1998, issue of THE JOURNAL (1998;279:346), there was incorrect wording under the heading "Two New Warnings Added to Labeling for Mibefradil." Mibrefadil is not contraindicated for patients concurrently receiving fluvastatin. The 2 drugs for which a new warning states that concurrent use with Mibefradil is contraindicated are lovastatin and simvastatin.

Journal

JAMAAmerican Medical Association

Published: Mar 25, 1998

There are no references for this article.